Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Obesity × Pregabalin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Pain, Postoperative 7 Neuralgia 4 Breast Neoplasms 4 Pain 3 Head and Neck Neoplasms 2 Chronic Pain 2 Agnosia 2 Visceral Pain 1 Spinal Cord Neoplasms 1 Seizures 1 Pinealoma 1 Persistent Postoperative Pain 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Oligodendroglioma 1 Obesity 1 Neuroectodermal Tumors, Primitive 1 Neoplasms 1 Meningioma 1 Medulloblastoma 1 Lymphoma, Follicular 1 Lymphoma 1 Liver Neoplasms 1 Leiomyoma 1 Inflammation 1 Hot Flashes 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Ependymoma 1

Interventions

Exercise 22 Metformin 14 Tirzepatide 8 Diet 8 Resistance Training 7 Nutrition Assessment 7 Methods 7 Diet Therapy 7 Counseling 6 semaglutide 5 Exenatide 5 Early Intervention, Educational 5 Diet, Mediterranean 5 Caloric Restriction 5 Blood Specimen Collection 5 Surveys and Questionnaires 4 Liraglutide 4 Educational Status 4 Bariatric Surgery 4 Vitamin D 3 Standard of Care 3 Naltrexone 3 Letrozole 3 Docosahexaenoic Acids 3 Dexamethasone 3 Bupropion 3 exemestane 2 bupropion hydrochloride, naltrexone hydrochoride drug combination 2 Yoga 2 Topiramate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡